{"effective_time":"20210113","id":"73719d28-525b-4201-94ff-442e81bbb718","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label 1 mL NDC 0409-1800-01 Neo-Synephrine ® HCl Rx only phenylephrine HCl injection, USP 10 mg/mL 1% Solution Hospira, Inc. Lake Forest, IL 60045 USA RL-1423 (11/05) PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label","PRINCIPAL DISPLAY PANEL - 1 mL Ampule Cello Pack Label 1 mL (10 mg) Single-dose 5 Ampuls NDC 0409-1800-01 Neo-Synephrine ® HCl phenylephrine hydrochloride injection, USP 1% Sterile Aqueous Injection FOR PARENTERAL USE Rx only PROTECT FROM LIGHT. Each mL contains 10 mg NEO-SYNEPHRINE hydrochloride, brand of phenylephrine hydrochloride, 3.5 mg sodium chloride, 4 mg sodium citrate, 1 mg citric acid monohydrate, and not more than 2 mg sodium metabisulfite as preservative. For usual dosage and route of administration, see package insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] WARNING: CONTAINS SULFITES. Printed in USA Hospira, Inc., Lake Forest, IL 60045 USA Hospira RL-2067 (3/07) PRINCIPAL DISPLAY PANEL - 1 mL Ampule Cello Pack Label"],"set_id":"120aa498-4834-4855-b74c-a02a93d5cf7f","spl_product_data_elements":["Neo-Synephrine Hydrochloride phenylephrine hydrochloride PHENYLEPHRINE HYDROCHLORIDE PHENYLEPHRINE SODIUM CHLORIDE SODIUM CITRATE, UNSPECIFIED FORM CITRIC ACID MONOHYDRATE SODIUM METABISULFITE"],"version":"4"}